Ekso Bionics
Ekso Bionics develops wearable robotic exoskeletons for rehabilitation and industrial use, enhancing mobility for individuals with various neurological conditions and improving productivity in industrial settings.
Services
Ekso Bionics develops wearable robotic exoskeletons for both rehabilitation and industrial applications. They offer EksoNR for rehabilitation purposes and Ekso EVO for industrial use. Their solutions cater to individuals with spinal cord injuries, stroke, acquired brain injury, and multiple sclerosis. Beyond products, they provide a comprehensive training program for clinicians to effectively use their exoskeleton devices.
Products
Ekso Bionics offers several flagship products including EksoNR and Ekso EVO. EksoNR is FDA-cleared for use with acquired brain injury, stroke, multiple sclerosis, and spinal cord injury. Ekso EVO is tailored for industrial applications, designed to reduce workplace injuries and enhance productivity. They also have a cloud-based platform called EksoPulse, which aids in monitoring patient progress and outcomes.
Sector
Ekso Bionics operates within the sectors of medical rehabilitation and industrial safety. Their technologies are aimed at increasing mobility and quality of life for individuals with significant physical disabilities and enhancing workplace safety and productivity in industrial settings.
History
Ekso Bionics is headquartered in Northern California, with offices in Europe, Asia, and North America. The company collaborates with respected research institutions such as Johns Hopkins and the Kessler Institute to advance robotic-assisted therapy technologies. Ekso Bionics has built a robust distributor network that spans continents, including North America, Europe, and Asia.
Research and Partnerships
Ekso Bionics engages in research partnerships with institutions such as Johns Hopkins and the Kessler Institute. These collaborations aim to advance the development of robotic-assisted therapies, leveraging Ekso Bionics' technology and expertise in wearable electronics and robotics. These partnerships play a crucial role in continuously improving the therapeutic efficacy of their products.